Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03762668 · ClinicalTrials.gov registry record · NA
Performance Assessment of a Modified Daily Disposable Contact Lens
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT03762668: Completed NA study, sponsored by Alcon Research.
NCT03762668 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03762668, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to compare visual acuity between two daily disposable contact lenses.
Primary Outcome
Distance visual acuity (VA) testing was performed using letter charts. Each row of the chart contained 5 letters, with the letters on each row progressively smaller than the row above. The subject read the letters from larger to smaller. The test terminated when the subject either misidentified a majority of letters on 1 row or progressed to the smallest row of letters. Visual acuity scoring sheets were used to record the number of letters correctly read. LogMAR VA was calculated based on the to
Interventions
- DEVICE Delefilcon A contact lenses
- DEVICE Modified delefilcon A contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2018-12-03 |
| Est. Completion | 2019-01-07 |
| Phase | NA |
What the finished NCT03762668 record still lists
NCT03762668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Delefilcon A contact lenses is the first listed.
NCT03762668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03762668 about?
NCT03762668 is a clinical study titled "Performance Assessment of a Modified Daily Disposable Contact Lens". The purpose of this study is to compare visual acuity between two daily disposable contact lenses.
What is the current status of trial NCT03762668?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2018-12-03. Estimated completion is 2019-01-07.
What interventions are being tested in trial NCT03762668?
The interventions under investigation include: Delefilcon A contact lenses (DEVICE), Modified delefilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT03762668?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03762668's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI